- Companies
- Enfusion
Enfusion Acquisition, Valuation, Funding & Investors
Enfusion was acquired by Clearwater Analytics for $1.5B in January 2025, a 7.4x multiple on $198M of revenue.
Enfusion revenue at acquisition
$198M
Last twelve months · Jan 2025
Enfusion revenue multiple at acquisition
7.4x
EV/Revenue · Jan 2025
Enfusion EBITDA multiple at acquisition
83.9x
EV/EBITDA · Jan 2025
About Enfusion
Enfusion is a Chicago-headquartered SaaS provider of integrated portfolio management, risk analytics, and middle-office solutions for asset managers globally. It supports over 800 investment firms managing $1.2 trillion in assets across hedge funds, private equity, and real assets. The cloud platform handles multi-asset class trading, compliance reporting, and NAV calculations with 99.99 percent uptime. Enfusion went public on NYSE in 2023 under ticker ENFN.
Founded
1998
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Subscription
Revenue
$80M (Jan 2021)
Valuation
$1.5B (Jan 2021)
Enfusion Acquisition
Enfusion was acquired by Clearwater Analytics for $1.5B on 13 January 2025.
The acquisition price implies a 7.4x revenue and 83.9x EBITDA multiple on $198M of revenue.
Before the acquisition Enfusion had raised $156M across 2 funding rounds.
| Acquirer | Date | Type | Price | EV/Revenue | EV/EBITDA |
|---|---|---|---|---|---|
| 13 Jan 2025 | Strategic M&A | $1.5B | 7.4x | 83.9x |
Enfusion Valuation
Enfusion is currently valued at $1.5B, based on its undisclosed-stage round in January 2021.
The $150M round was led by ICONIQ Capital.
Enfusion valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jan 2021 | Undisclosed stage | $1.5B | 18.8x |
Enfusion Revenue
Enfusion's latest recorded revenue is $80M, as of its undisclosed-stage round in January 2021. At a $1.5B valuation, that implies a 18.8x revenue multiple.
Enfusion revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jan 2021 | $80M | $1.5B | 18.8x | Undisclosed stage |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Enfusion Funding History
Enfusion has raised a total of $156M across 2 funding rounds.
Enfusion's first fundraising round was a $6M Series A in January 2015. The most recent completed round was a $150M undisclosed-stage round in January 2021.
Enfusion funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jan 2021 | Undisclosed stage | ICONIQ Capital (lead) | $150M | $1.5B | Enfusion is a global leader in cloud-native SaaS investment management technology solutions, providing integrated front-to-back office software and services that simplify workflows, unify data, and enable investment managers to focus on decision-making. The company serves over 550 clients from nine global offices and achieved record growth in 2020, signing 160 new fund managers and posting triple-digit client growth in APAC. On January 11, 2021, Enfusion announced a $150 million minority growth equity investment led by ICONIQ Growth, valuing the company at $1.5 billion post-money. ICONIQ Growth joined existing institutional investors FTV Capital and Hillhouse Capital. The funding endorses Enfusion's pioneering approach to modernizing outdated front, middle, and back-office systems amid industry shifts away from legacy technology. The investment supports Enfusion's expansion, particularly into new markets like Asia Pacific, and fuels global hiring after a 78% team growth in 2020. Enfusion emphasized its continued profitability and client momentum as key factors aligning with the valuation. |
| Jan 2015 | Series A | - | $6M | - | - |
Who has invested in Enfusion?
1 investor has backed Enfusion across its funding rounds, including ICONIQ Capital.
Lead investors include ICONIQ Capital.
Enfusion Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Enfusion investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialEnfusion Competitors
Enfusion competitors include listed companies like Intapp, Topicus, SS&C Technologies and Shenzhen Kingdom Sci-tech, and private ones like Built Technologies and Snapdocs.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $578M | ($16M) | $2.8B | 4.5x | ||
| Publicly listed | $1.8B | $393M | $5.4B | 3.0x | ||
| Publicly listed | $6.3B | $2.1B | $19B | 3.9x | ||
| Publicly listed | $361M | ($15M) | $1.5B | 3.9x | ||
| Private | $83M | - | $1.5B | 18.1x | ||
| Private | $152M | - | $1.5B | 9.9x |
Enfusion Public Comps
Enfusion is no longer listed, but its public comps include Shenzhen Kingdom Sci-tech, eFinance, Pagaya, Yusys Technologies, Donnelley Financial Solutions, Shenzhen Sunline, Porch Group, Aisino, Optasia and Computer Age Management Services.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $361M | ($15M) | 4.0x | 3.9x | (96.0x) | 141.9x | |||
| $130M | $67M | 11.8x | - | 22.8x | - | |||
| $1.3B | $33M | 1.1x | 1.0x | 42.6x | 3.2x | |||
| $540M | $67M | 2.6x | 2.4x | 21.2x | 19.6x | |||
| $767M | $122M | 1.8x | 1.8x | 11.2x | 5.6x | |||
| $292M | $14M | 3.7x | 3.1x | 76.1x | 38.5x | |||
| $510M | $79M | 4.0x | 4.1x | 25.7x | 18.4x | |||
| $828M | ($46M) | 1.6x | - | (29.5x) | - | |||
This data is available for Pro users. Sign up to see all Enfusion competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Enfusion
| When was Enfusion founded? | Enfusion was founded in 1998. |
| Where is Enfusion headquartered? | Enfusion is headquartered in Chicago, IL, United States. |
| Is Enfusion publicly listed? | No, Enfusion was acquired by Clearwater Analytics in January 2025. |
| Who acquired Enfusion? | Enfusion was acquired by Clearwater Analytics in January 2025. |
| How much was Enfusion acquired for? | Enfusion was acquired for $1.5B in January 2025, a 7.4x revenue multiple. |
| What is Enfusion's valuation? | Enfusion was last valued at $1.5B in its undisclosed-stage round in January 2021. |
| How much funding has Enfusion raised? | Enfusion has raised $156M across 2 funding rounds. |
| What was Enfusion's last funding round? | Enfusion's last funding round was a $150M undisclosed-stage round in January 2021, led by ICONIQ Capital. |
| Who are Enfusion's investors? | Enfusion's investors include ICONIQ Capital. |
| What is Enfusion's revenue? | Enfusion's latest recorded revenue is $80M (January 2021). |
| What is Enfusion's revenue multiple? | Enfusion's latest valuation implies a 18.8x revenue multiple ($1.5B valuation on $80M of revenue). |
| Which companies are comparable to Enfusion? | Companies comparable to Enfusion include Intapp, Topicus, SS&C Technologies, Shenzhen Kingdom Sci-tech, Built Technologies and Snapdocs. |
See companies similar to Enfusion
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




